These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28150448)

  • 1. PPAR-γ agonist ameliorates liver pathology accompanied by increasing regulatory B and T cells in high-fat-diet mice.
    Xu Z; Wang G; Zhu Y; Liu R; Song J; Ni Y; Sun H; Yang B; Hou M; Chen L; Ji M; Fu Z
    Obesity (Silver Spring); 2017 Mar; 25(3):581-590. PubMed ID: 28150448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pioglitazone mediated activation of PPAR-γ on CIDEC and obesity related changes in mice.
    Shamsi BH; Ma C; Naqvi S; Xiao Y
    PLoS One; 2014; 9(9):e106992. PubMed ID: 25210844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
    van der Veen JN; Lingrell S; Gao X; Quiroga AD; Takawale A; Armstrong EA; Yager JY; Kassiri Z; Lehner R; Vance DE; Jacobs RL
    Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G526-38. PubMed ID: 26797396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR-
    Zhu Y; Ni Y; Liu R; Hou M; Yang B; Song J; Sun H; Xu Z; Ji M
    J Immunol Res; 2018; 2018():6398078. PubMed ID: 30116754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice.
    Choi BH; Jin Z; Yi CO; Oh J; Jeong EA; Lee JY; Park KA; Kim KE; Lee JE; Kim HJ; Hahm JR; Roh GS
    PLoS One; 2018; 13(7):e0200336. PubMed ID: 29979770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver.
    Zhu YX; Zhang ML; Zhong Y; Wang C; Jia WP
    J Diabetes Res; 2016; 2016():8315454. PubMed ID: 26770990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
    Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
    Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding.
    Jovicic N; Jeftic I; Jovanovic I; Radosavljevic G; Arsenijevic N; Lukic ML; Pejnovic N
    PLoS One; 2015; 10(7):e0134089. PubMed ID: 26218873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-33 Reverses an Obesity-Induced Deficit in Visceral Adipose Tissue ST2+ T Regulatory Cells and Ameliorates Adipose Tissue Inflammation and Insulin Resistance.
    Han JM; Wu D; Denroche HC; Yao Y; Verchere CB; Levings MK
    J Immunol; 2015 May; 194(10):4777-83. PubMed ID: 25870243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-27 signaling resists obesity by promoting the accumulation of Treg cells in visceral adipose tissue.
    Jiang T; Zou A; Song W; Zheng J; Lai L; Wang Q; Cui B
    Biochem Biophys Res Commun; 2024 Nov; 733():150690. PubMed ID: 39276693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Outcomes of Rosiglitazone Treatment on Fatty Liver.
    Gao M; Ma Y; Alsaggar M; Liu D
    AAPS J; 2016 Jul; 18(4):1023-31. PubMed ID: 27125895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Korean red ginseng (Panax ginseng) inhibits obesity and improves lipid metabolism in high fat diet-fed castrated mice.
    Shin SS; Yoon M
    J Ethnopharmacol; 2018 Jan; 210():80-87. PubMed ID: 28844680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An experimental study on the reverse mechanism of PPAR-gamma agonist rosiglitazone in rats with non-alcoholic steatohepatitis].
    Zhao CY; Wang YD; Zhou JY; Jia B; Cui JF
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):450-5. PubMed ID: 17594812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ursolic acid and Rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice.
    Sundaresan A; Radhiga T; Pugalendi KV
    Eur J Pharmacol; 2014 Oct; 741():297-303. PubMed ID: 25149666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice.
    Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM
    J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt.
    Jia Y; Wu C; Kim J; Kim B; Lee SJ
    J Nutr Biochem; 2016 Feb; 28():9-18. PubMed ID: 26878778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl dehydroabietate counters high fat diet-induced insulin resistance and hepatic steatosis by modulating peroxisome proliferator-activated receptor signaling in mice.
    Yoshioka H; Mizuno Y; Yamaguchi T; Ichimaru Y; Takeya K; Hitotsuyanagi Y; Nonogaki T; Aoyagi Y
    Biomed Pharmacother; 2018 Mar; 99():214-219. PubMed ID: 29334664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.
    Kim J; Lee H; Lim J; Oh J; Shin SS; Yoon M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
    Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
    Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.